Sarah Cannon Cancer Center — Nashville, Tennessee

Sarah Cannon Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Sarah Cannon Cancer Center has participated in 67 clinical trials with 13 currently active.

Therapeutic areas: Breast Cancer, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms.

Sponsors: Eli Lilly and Company, CTI BioPharma, Celgene.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Cancer Center?

Sarah Cannon Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Cancer Center conducted?

Sarah Cannon Cancer Center has 67 clinical trials on record, with 13 currently active. Their work covers Breast Cancer, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms.

Is Sarah Cannon Cancer Center accredited by Crixeo Health?

Sarah Cannon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.